[1]
|
Wang BN, Zheng H. From blanket quarantine in Wuhan to distant centralized quarantine in Shijiazhuang: the evolution of China’s COVID-19 quarantine approach. Infection 2021;49(4):765 − 7. http://dx.doi.org/10.1007/s15010-021-01623-8CrossRef
|
[2]
|
Wu T, Ge YY, Zhao KC, Zhu XJ, Chen Y, Wu B, et al. A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). Virology 2020;549:1 − 4. http://dx.doi.org/10.1016/j.virol.2020.07.006CrossRef
|
[3]
|
Xue GH, Li SL, Zhang WW, Du B, Cui JH, Yan C, et al. Reverse-transcription recombinase-aided amplification assay for rapid detection of the 2019 novel coronavirus (SARS-CoV-2). Anal Chem 2020;92(14):9699 − 705. http://dx.doi.org/10.1021/acs.analchem.0c01032CrossRef
|
[4]
|
Wang J, Cai K, He X, Shen X, Wang J, Liu J, et al. Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA. Clin Microbiol Infect 2020;26(8):1076 − 81. http://dx.doi.org/10.1016/j.cmi.2020.05.007CrossRef
|
[5]
|
Adeola F. Normalization of gene expression by quantitative RT-PCR in human cell line: comparison of 12 endogenous reference genes. Ethiop J Health Sci 2018;28(6):741 − 8. http://dx.doi.org/10.4314/ejhs.v28i6.9CrossRef
|
[6]
|
Liu FF , Zheng CJ, Wang LP, Geng MJ, Chen H, Zhou S, et al. Interpretation of the Protocol for Prevention and Control of COVID-19 in China (Edition 8). China CDC Weekly 2021;3(25):527 − 30. http://dx.doi.org/10.46234/ccdcw2021.138CrossRef
|
[7]
|
National Health Commission of the People’s Republic of China. SARS-CoV-2 laboratory biosafety guidelines 2020. http://www.nhc.gov.cn/yzygj/s7659/202012/b89bcd0813da41788688eb14787b3c72.shtml. [2022-5-19].http://www.nhc.gov.cn/yzygj/s7659/202012/b89bcd0813da41788688eb14787b3c72.shtml |
[8]
|
Krüttgen A, Cornelissen CG, Dreher M, Hornef MW, Imöhl M, Kleines M. Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit. J Virol Methods 2021;288:114024. http://dx.doi.org/10.1016/j.jviromet.2020.114024CrossRef
|
[9]
|
Okamaoto K, Shirato K, Nao N, Saito S, Kageyama T, Hasegawa H, et al. Assessment of real-time RT-PCR kits for SARS-CoV-2 detection. Jpn J Infect Dis 2020;73(5):366 − 8. http://dx.doi.org/10.7883/yoken.JJID.2020.108CrossRef
|
[10]
|
Wang RH, Zhang H, Zhang Y, Li XN, Shen XX, Qi JJ, et al. Development and evaluation of recombinase-aided amplification assays incorporating competitive internal controls for detection of human adenovirus serotypes 3 and 7. Virol J 2019;16(1):86. http://dx.doi.org/10.1186/s12985-019-1178-9CrossRef
|
[11]
|
Bai XD, Ma XJ, Li MH, Li XN, Fan GH, Zhang RQ, et al. Field applicable detection of hepatitis B virus using internal controlled duplex recombinase-aided amplification assay and lateral flow dipstick assay. J Med Virol 2020;92(12):3344 − 53. http://dx.doi.org/10.1002/jmv.25778CrossRef
|